Study: Gemcitabine helps prevent recurrence of low-grade bladder cancer
May 16, 2018
A multi-institution clinical trial involving researchers from UT Health San Antonio shows significantly lower recurrence of bladder cancer in patients who received the chemotherapy drug gemcitabine.